CABG Linked with Better Long-Term Outcomes than PCI in ESRD and CKD Patients

A meta-analysis of 17 trials found coronary artery bypass grafting (CABG) decreased late mortality risk by 14% and 18% in patients with ESRD and CKD, respectively, compared to percutaneous coronary intervention (PCI). However, CABG was associated with a 2.0 and 2.5 times increased risk of early mortality in ESRD and CKD patients, respectively, compared to PCI. In ESRD patients, CABG demonstrated a 66% decreased risk of myocardial infarction compared to PCI. The American Journal of Therapeutics findings noted CABG was associated with an 88% and 73% decreased risk of repeat revascularization in ESRD and CKD patients, respectively.